Hofseth Biocare ASA :Meldepliktig handel Primærinnsider i HBC

December 30, 2016 09:25 ET | Source: Hofseth Biocare ASA Hofseth Biocare ASA

Angelika Florvaag, kvalitetssjef i Hofseth Biocare ASA, har i dag 30.12.2016 kjøpt 10.000 aksjer til snittkurs 1,20 pr aksje i Hofseth BioCare ASA. Etter dette har Angelika Florvaag 10.000 aksjer i Hofseth BioCare ASA, tilsvarende 0,004 % av aksjene i Hofseth BioCare ASA.

Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12

Recommended Reading

December 15, 2025 04:04 ET | Source: Hofseth Biocare ASA

Hofseth BioCare ASA: Cancellation of Subsequent Offering – Update on completion of Private Placement

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR...
Read More
November 21, 2025 04:28 ET | Source: Hofseth Biocare ASA

Hofseth BioCare ASA: PRIMARY INSIDER NOTIFICATION

Christoph Baldegger, primary insider and member of the Board of Directors in Hofseth BioCare ASA ("HBC"), has subscribed for 368,320 Offer shares in the Subsequent Offering and Mr. Baldegger will hold...
Read More